| abstract |
(57) [Summary] (Modified) [Objective] To provide a novel chromanyloxyalkylamine derivative having an affinity for the 5HT 1A receptor. [Structure] A chromanyloxyalkylamine derivative represented by the general formula (I) or a salt thereof. (The symbols in the formulas have the following meanings: R 1 : a hydrogen atom or a lower alkyl group; R 2 : a lower alkoxy group; Y: a lower alkylene group). It can be used to treat various diseases involving the HT nervous system, such as anxiety, tension and depression, psychiatric diseases such as schizophrenia, sexual dysfunction, food intake disorder, sleep disorder, and the like. |